Relationship between Peripheral Blood Eosinophil Count and Neutrophil/Lymphocyte Ratio with Number of Attacks Leading to Hospital Admission in Chronic Obstructive Pulmonary Disease

Mirzaee, Maryam; Abbasi, Mohammad Amin; Fadaii, Abbas

Volume 6, Issue 4 (12-2020) Journal of Research in Applied and Basic Medical Sciences 2020, 6(4): 272-278 | Back to browse issues page

Mendeley

Zotero

RefWorks

Mirzaee M, Abbasi M A, Fadaii A. Relationship between Peripheral Blood Eosinophil Count and Neutrophil/Lymphocyte Ratio with Number of Attacks Leading to Hospital Admission in Chronic Obstructive Pulmonary Disease. Journal of Research in Applied and Basic Medical Sciences 2020; 6 (4) :272-278
URL: http://ijrabms.umsu.ac.ir/article-1-140-en.html

Relationship between Peripheral Blood Eosinophil Count and Neutrophil/Lymphocyte Ratio with Number of Attacks Leading to Hospital Admission in Chronic Obstructive Pulmonary Disease

Maryam Mirzaee

, Mohammad Amin Abbasi

, Abbas Fadaii ^*

Department of Pulmonology and Intensive Care Medicine, Shahid Labbafinejad Hospital , basfadaii@gmail.com

Abstract: (2104 Views)

Background & Aims: Chronic obstructive pulmonary disease is an important common respiratory disorder. Determination of the prognostic factors is important to improve the outcomes and decrease the burden of problem. We aimed to determine the relationship between peripheral blood eosinophil count and neutrophil/lymphocyte ratio (NLR) with number of attacks leading to hospital admission in patients with chronic obstructive pulmonary disease.
Materials & Methods: In this cohort study, 200 consecutive patients with chronic obstructive pulmonary disease from 2016 to 2018 were enrolled including those with and without attacks leading to hospital admission and eosinophil and NLR were compared in them.
Results: The results in this study demonstrated that mean eosinophil was 1.5 and 1.4 in those without and with attack without significant difference (p=0.641). The mean NLR was 4.6 and 5.9 in those without and with attack with significant difference (p=0.022).
Conclusion: Totally, according to the obtained results, it is concluded that higher NLR is related to further attacks leading to hospital admissions but the eosinophil count has no significant effect in this area.

Keywords: Eosinophil, NLR, COPD, Exacerbation

Full-Text [PDF 328 kb] (1343 Downloads)

Type of Study: orginal article | Subject: General

References

1. Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012; 7:457-94. [DOI:10.2147/COPD.S32330] [PMID] [PMCID]

2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370(9589):765-73. [DOI:10.1016/S0140-6736(07)61380-4]

3. Martin A, Badrick E, Mathur R, Hull S. Effect of ethnicity on the prevalence, severity, and management of COPD in general practice. Br J Gen Pract 2012;62(595):e76-81. [DOI:10.3399/bjgp12X625120] [PMID] [PMCID]

4. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186(2):155-61. [DOI:10.1164/rccm.201201-0034OC] [PMID]

5. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009;374(9691):721-32. [DOI:10.1016/S0140-6736(09)61290-3]

6. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128. [DOI:10.1016/S0140-6736(12)61728-0]

7. Kasper D, Braunwald E, Hauser S, Longo D, Larry Jameson J, Fauci A. Harrison's Principle of Internal Medicine. 16th ed. McGraw- Hill, 2005. P. 1547-51. [Google Scholar]

8. Steven D, Shapiro MD, Gordon L, Snider MD, Stephen I, Rennard M. Chronic Bronchitis and Emphysema. In: Murray JF, Nadel J. Text book of respiratory medicine. 4th ed. Philadelphia: Elsevier Saunders; 2005.P. 1116-27.

9. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22. [DOI:10.1164/ajrccm.157.5.9709032] [PMID]

10. Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:39-47. [DOI:10.2147/copd.2006.1.1.39] [PMID] [PMCID]

11. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011;184: 662-71. [DOI:10.1164/rccm.201104-0597OC] [PMID]

12. Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebocontrolled trial. Am J Respir Crit Care Med 2012; 186:48-55. [DOI:10.1164/rccm.201108-1553OC] [PMID] [PMCID]

13. Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015; 3:435-42. [DOI:10.1016/S2213-2600(15)00106-X]

14. Siddiqui SH, Guasconi A, Vestbo J, Jones P, Agusti A, Paggiaro P, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192:523-5. [DOI:10.1164/rccm.201502-0235LE] [PMID] [PMCID]

15. Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. Am J Respir Crit Care Med. 2016;193(9):965-74. [DOI:10.1164/rccm.201509-1869OC] [PMID]

16. Çoban Ağca M, Aksoy E, Duman D, Özmen İ, Yıldırım E. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation? Tuberk Toraks 2017;65(4):282-90. [DOI:10.5578/tt.57278] [PMID]

17. Song JH, Lee CH, Kim JW, Lee WY, Jung JY, Park JH, et al. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlapsyndrome COPD. Int J Chron Obstruct Pulmon Dis 2017; 12:2455-64. [DOI:10.2147/COPD.S129321] [PMID] [PMCID]

18. Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysisof data from two parallel randomised controlled trials. Lancet Respir Med 2015;3(6):435-42. [DOI:10.1016/S2213-2600(15)00106-X]

19. Ye Z, Ai X, MD, Liao Z, You C, Cheng Y. The prognostic values of neutrophil to lymphocyte ratio for outcomes in chronic obstructive pulmonary disease. Medicine (Baltimore) 2019; 98(28): e16371. [DOI:10.1097/MD.0000000000016371] [PMID] [PMCID]

20. Teng F, Ye H, Xue T. Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One 2018; 13(9): e0204377. [DOI:10.1371/journal.pone.0204377] [PMID] [PMCID]

21. Liu J, Liu J, Zou Y. Relationship between neutrophil-lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbationBiosci Rep 2019; 39(5): BSR20190675. [DOI:10.1042/BSR20190675] [PMID] [PMCID]

22. El-Gazzar AG, Kamel MH, Elbahnasy OKM, El-Naggar ME. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. Expert Rev Respir Med 2020;14(1):111-6 [DOI:10.1080/17476348.2019.1675517] [PMID]